首页> 外文会议>International Conference onattern Recognition Applications and Methods >Assessment of Dendritic Cell Therapy Effectiveness Based on the Feature Extraction from Scientific Publications
【24h】

Assessment of Dendritic Cell Therapy Effectiveness Based on the Feature Extraction from Scientific Publications

机译:基于科学出版物特征提取的树突细胞治疗效果评估

获取原文

摘要

Dendritic cells (DCs) vaccination is a promising way to contend cancer metastases especially in the case of immunogenic tumors. Unfortunately, it is only rarely possible to achieve a satisfactory clinical outcome in the majority of patients treated with a particular DC vaccine. Apparently, DC vaccination can be successful with certain combinations of features of the tumor and patients immune system that are not yet fully revealed. Difficulty in predicting the results of the therapy and high price of preparation of individual vaccines prevent wider use of DC vaccines in medical practice. Here we propose an approach aimed to uncover correlation between the effectiveness of specific DC vaccine types and personal characteristics of patients to increase efficiency of cancer treatment and reduce prices. To accomplish this, we suggest two-step analysis of published clinical trials results for DCs vaccines: first, the information extraction subsystem is trained, and, second, the extracted data is analyzed using JSM and AQ methodology.
机译:树突状细胞(DCS)疫苗接种是一种有希望的方法,尤其是在免疫原性肿瘤的情况下抗衡癌症转移。不幸的是,在用特定DC疫苗治疗的大多数患者中,才有很少可能在大多数患者中实现令人满意的临床结果。显然,DC疫苗接种可以成功地具有尚未完全揭示的肿瘤和患者免疫系统的某些组合。难以预测治疗结果和个体疫苗的高价格,防止在医疗实践中更广泛地使用DC疫苗。在这里,我们提出了一种旨在揭示特定直流疫苗类型的有效性与患者个人特征之间的相关性的方法,以提高癌症治疗效率并降低价格。为实现这一目标,我们建议对DCS疫苗的发布临床试验结果进行两步分析:首先,使用JSM和AQ方法分析信息提取子系统的培训,并分析提取的数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号